Bone metastasis of a breast cancer detected by 3'-deoxy-3'-¹⁸F-fluorothymidine PET/CT

• References

• 1 Uematsu T, Yuen S, Yukisawa S. et al. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol 2005; 184: 1266-1273.
• 2 Pio BS, Park CK, Pietras R. et al. Usefulness of 3'-¹⁸F-fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy. Mol Imaging Biol 2006; 8: 36-42.
• 3 Kenny L, Coombes RC, Vigushin DM. et al. Imaging early changes in proliferation at 1 week post chemotherapy : a pilot study in breast cancer patients with 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography. Eur J Nucl Med Mol Imaging 2007; 34: 1339-1347.
• 4 Dittmann H, Dohmen BM, Paulsen F. et al. [¹⁸F]FLT PET for diagnosis and staging of thoracic tumors. Eur J Nucl Med Mol Imaging 2003; 30: 1407-1412.